[Clinical experiences with a new muscle relaxant ah 8165--a derivate from azobis-arylimidazo-pyridinium (author's transl)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000758:Anesthesia; D000769:Anesthesia, Inhalation; D001391:Azo Compounds / Q000008:administration & dosage* / Q000009:adverse effects; D001794:Blood Pressure / Q000187:drug effects; D002648:Child; D004562:Electrocardiography; D006221:Halothane; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects; D007442:Intubation, Intratracheal; D007649:Ketamine; D008875:Middle Aged; D003473:Neuromuscular Nondepolarizing Agents; D011726:Pyridinium Compounds / Q000008:administration & dosage* / Q000009:adverse effects; D013390:Succinylcholine / Q000008:administration & dosage; D013874:Thiopental; D013997:Time Factors
D001391:Azo Compounds; D007093:Imidazoles; D003473:Neuromuscular Nondepolarizing Agents; D011726:Pyridinium Compounds; D007649:Ketamine; D013390:Succinylcholine; D013874:Thiopental; D006221:Halothane
Klinische Erfahrungen mit einem neuen Muskelrelaxans AH 8165--EIN Azobis-arylimidazo-pyridinium-Derivat